Insulin Recombinant Human; Insulin Susp Isophane Recombinant Human was first introduced by Eli Lilly And Co in its drug Humulin 70/30 on Apr 25, 1989. Other drugs containing Insulin Recombinant Human; Insulin Susp Isophane Recombinant Human are Novolin 70/30, Humulin 50/50, Humulin 70/30 Pen. 2 different companies have introduced drugs containing Insulin Recombinant Human; Insulin Susp Isophane Recombinant Human.

Insulin Recombinant Human; Insulin Susp Isophane Recombinant Human Patents

Given below is the list of patents protecting Insulin Recombinant Human; Insulin Susp Isophane Recombinant Human, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Humulin 70/30	US7291132	Medication dispensing apparatus with triple screw threads for mechanical advantage	Aug 09, 2024 (Expired)	Lilly
Humulin 70/30 Pen	US7291132	Medication dispensing apparatus with triple screw threads for mechanical advantage	Aug 09, 2024 (Expired)	Lilly

Add above patents to watchlist

Insulin Recombinant Human; Insulin Susp Isophane Recombinant Human's Family Patents

Full family tree